Boston Scientific: Adding Another Growth Engine With Penumbra [Seeking Alpha]
Boston Scientific Corporation (BSX)
Last boston scientific corporation earnings: 4/29 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.bostonscientific.com
Company Research
Source: Seeking Alpha
The company continues its M&A strategy now, including a large $15 billion deal to Penumbra, a larger deal which involves quite some debt now. In between a pullback, forward earnings multiples come in below 30 times earnings, amidst still strong (organic) growth, yet Boston has taken on quite some debt. Despite a premium 30x earnings multiple, Boston's 15% organic growth, M&A track record, and manageable leverage justify close monitoring for opportunistic entry on dips. Looking for more investing ideas like this one? Get them exclusively at Value In Corporate Events. Learn More » Sundry Photography/iStock Editorial via Getty Images Towards the end of October, I concluded that Boston Scientific ( BSX was continuing its M&A playbook, just as organic achievements were impressive. Supported by nearly 20% organic sales growth, shares commanded premium earnings valuations in the More on my IG service If you like to see more ideas, please subscribe to the premium service "Value
Show less
Read more
Impact Snapshot
Event Time:
BSX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BSX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BSX alerts
High impacting Boston Scientific Corporation news events
Weekly update
A roundup of the hottest topics
BSX
News
- Boston Scientific (NYSE:BSX) was given a new $115.00 price target on by analysts at National Bankshares, Inc..MarketBeat
- Boston Scientific (NYSE:BSX) had its "buy" rating reaffirmed by analysts at TD Cowen.MarketBeat
- How Surging Heart-Device Demand And Margin Gains At Boston Scientific (BSX) Has Changed Its Investment Story [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Reshapes Portfolio With Nalu And Penumbra Neuro Deals [Yahoo! Finance]Yahoo! Finance
- Boston Scientific Expands Neuromodulation And Obesity Trials As Valuation Stays Rich [Yahoo! Finance]Yahoo! Finance
BSX
Earnings
- 10/22/25 - Beat
BSX
Sec Filings
- 1/21/26 - Form 425
- 1/15/26 - Form 8-K
- 1/15/26 - Form 8-K
- BSX's page on the SEC website